We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Commission granted conditional marketing authorization for Moderna’s highly effective COVID-19 vaccine Wednesday, adding a second messenger RNA-based vaccine to its arsenal against the pandemic. Read More
The once-a-week therapy “could help reduce the burden of daily growth hormone injections on children, their loved ones and caregivers,” said Brenda Cooperstone, Pfizer’s chief development officer for rare diseases. Read More
The agency said that Amphastar’s generic drug is a synthetic version of human glucagon, a hormone that prompts the liver to quickly increase blood sugar levels. Read More
Despite the serious challenges the FDA faced in responding to the COVID-19 pandemic in 2020, the agency ended the year approving more novel drugs than in four of the five previous years. Read More
India on Sunday granted emergency use approval for the COVID-19 vaccine co-developed by AstraZeneca (AZ) and Oxford University — formerly known as AZD1222 but now called COVID-19 Vaccine AstraZeneca — along with a separate vaccine, Covaxin, developed by Bharat Biotech. Read More
On Wednesday, the UK authorized AstraZeneca’s (AZ) and Oxford University’s COVID-19 vaccine for emergency use, characterized as a rapid temporary regulatory approval, becoming the first country to do so as the nation contends with a new contagious strain of the virus leading to a spike in cases. Read More
The blockbuster drug is the first poly (ADP ribose) polymerase (PARP) inhibitor approved in Japan for treating three specific types of cancer. Read More